ArticleRSC advances2023
Gemini ionic liquid-based surfactants: efficient synthesis, surface activity, and use as inducers for the fabrication of Cu
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Gemini Surfactants: Advances in Applications and Prospects for the Future.Molecules (Basel, Switzerland) · 2025Review
- Development and Characterization of a Novel Erucyl Ultra-Long-Chain Gemini Surfactant.Polymers · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Discovery of green and novel synthetic routes for nanoparticles (NPs) has drawn a lot of interest due to the distinct nano size and unusual features as well as applications of such particles. Ionic liquid-based surfactants (ILBSs) and gemini ionic liquid-based surfactants (GILBSs) have become some of the best choices to be used as inducers or dispersing agents for the fabrication of nanoparticles. This work involves the synthesis, spectroscopic characterization, and surface property evaluation of three novel GILBSs (4a-c), which incorporate the imidazolium cation as the polar head with an ethylene spacer. The simple synthetic route includes, first, alkylating imidazole-N1 with the as-prepared fatty alkyl chloroacetates followed by quaternization of two equivalents of imidazole-N2 with ethylene dibromide. Investigations into the compounds' surface characteristics and thermodynamic parameters were carried out. The prepared GILBSs, 4a-c, were then used as inducers at various concentrations for the preparation of cuprous oxide nanoparticles. The size and shape of the produced NPs were examined by X-ray diffraction (XRD) and transmission electron microscopy (TEM) analysis in each case to study the effect of concentration on the NP morphology and to determine the best concentration for the NPs fabrication. The XRD patterns of the produced Cu
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.